insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$1,64
arrow_downward
-4,09%(-0,070) 1D
US$1,66
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$1,69
High
US$1,78
Low
US$1,63
Mkt. cap
253,12 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
2,68 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,63
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,69
High
US$1,78
Low
US$1,63
Mkt. cap
253,12 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
2,68 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,63
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
24/7 Wall St.
·
28 ນາທີກ່ອນ
The S&P 500 Is Having the Longest Losing Streak Since February 2020
Beinsure
·
2 ຊົ່ວໂມງກ່ອນ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Trefis
·
12 ຊົ່ວໂມງກ່ອນ
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com